Stereotaxis GenesisX cleared by EU

The EU clearance of Stereotaxis’ endovascular robotic system “GenesisX” marks a significant advancement in the rapidly growing field of robotic-assisted surgery, according to GlobalData, a leading data and analytics company.

As the global market for these systems is set to surge, driven by the need for precision in minimally invasive procedures, this highlights the industry’s shift towards innovative technologies that improve surgical outcomes and redefine standards in interventional medicine, the analytics provider suggests.

GlobalData’s report, “Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033,” reveals that the global robotic surgical systems market will grow at a compound annual growth rate of more than 12% during 2023-2033.

Graysen Vigneux, Medical Analyst at GlobalData, comments: "This anticipated growth underscores the expanding demand in the market, driven by several key factors: the rising need for precise and minimally invasive surgical solutions among an aging population, a growing emphasis on value-based healthcare to improve surgical outcomes, and continuous technological advancements that are expected to yield more efficient and less invasive robotic surgical platforms.”

Stereotaxis says that GenesisX is designed to facilitate minimally invasive endovascular procedures, offering physicians enhanced control and precision. Leveraging advanced magnetic navigation technology, the system allows for precise manipulation of catheters within the vascular system, even in the most complex anatomical situations. This capability not only improves the accuracy and safety of procedures but also reduces the risk of complications, such as vessel damage or procedural errors.

As the system gains traction in Europe, it may set a precedent for the adoption of similar technologies in other regions, further driving the global market for robotic-assisted interventions.

Vigneux concludes: "Stereotaxis' achievement in securing EU clearance for GenesisX underscores the growing importance of robotics in enhancing the quality of care in interventional medicine. As hospitals and healthcare providers seek to improve outcomes and efficiency, the role of advanced robotic systems like Stereotaxis' will become increasingly critical."

Latest Issues

EBME Expo 2026

Coventry Building Society Arena, Coventry
24th – 25th June 2026

AfPP Regional Conferences: Manchester

INNSiDE by Meliá Manchester
20th June 2026

Endoscopic Anterior Skull Base Surgery: Hands-On Cadaveric Course

Division of Anatomy, University of Leeds
29th- 30th June 2026

BLOCKED – Advanced+ | The Wrightington Regional Anaesthesia Interest Group Cadaveric Course

Wrightington Conference Centre
Tuesday 7th – Wednesday 8th July 2026

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026